Cheryl Cohen Aadi Bioscience, Inc. (AADI) insider trading activity

AADI Quotes by TradingView

Cheryl Cohen is Director of Aadi Bioscience, Inc.. Currently has a direct ownership of 16,160 shares of AADI, which is worth approximately $51,873. The most recent transaction as insider was on Jun 30, 2021, when has been sold 8,140 shares (Common Stock) at a price of $1.52 per share, resulting in proceeds of $12,373. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.2K
0% 3M change
0% 12M change
Total Value Held $51,873

Cheryl Cohen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2021
BUY
Grant, award, or other acquisition
$12,373 $1.52 p/Share
8,140 Added 33.5%
16,160 Common Stock
Mar 31 2021
BUY
Grant, award, or other acquisition
$12,351 $1.54 p/Share
8,020 Added 50.0%
8,020 Common Stock

Also insider at

IBRX
ImmunityBio, Inc. Healthcare
Director
MEIP
MEI Pharma, Inc. Healthcare
Director
CLDX
Celldex Therapeutics, Inc. Healthcare
CC

Cheryl Cohen

Director
San Diego, CA

Track Institutional and Insider Activities on AADI

Follow Aadi Bioscience, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AADI shares.

Notify only if

Insider Trading

Get notified when an Aadi Bioscience, Inc. insider buys or sells AADI shares.

Notify only if

News

Receive news related to Aadi Bioscience, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AADI